GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Ipca Laboratories Ltd

Ipca Laboratories Q2 FY27 Standalone Net Profit Rises to Rs. 387.29 Crores

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 05 Nov 2026, 01:48 PM IST  ·  BSE ID: 8d031f7f-3217-4b42-8e49-cd801e7ac897
View Original BSE Filing (PDF)
💡
In Simple Terms
Ipca Laboratories reported increased revenue and profit for the second quarter and half year of its current financial year.
🤖 AI Summary
  • Ipca Laboratories' standalone revenue from operations reached Rs. 2,255.61 Crores for Q2 FY27.
  • Net profit for the period increased to Rs. 387.29 Crores in Q2 FY27 from Rs. 304.74 Crores in Q2 FY26.
  • Half-year standalone revenue from operations totaled Rs. 4,374.85 Crores for H1 FY27.
  • Basic/Diluted Earnings per share (after exceptional items) was Rs. 15.27 for the quarter ended September 30, 2026.
  • Total Equity stood at Rs. 8,576.48 Crores as of September 30, 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from operations (Q2 FY27)
2,255.61 Crores
16.85%
Profit for the period (Q2 FY27)
387.29 Crores
27.08%
Earnings per share (Basic/Diluted) (Q2 FY27)
15.27 Crores
27.14%
Revenue from operations (H1 FY27)
4,374.85 Crores
18.97%
Profit for the period (H1 FY27)
760.58 Crores
34.19%
Total Equity (as of Sep 30, 2026)
8,576.48 Crores
🏢 How This Affects the Company
📈
Business Impact
The increase in revenue from operations from Rs. 1,930.32 Crores in Q2 FY26 to Rs. 2,255.61 Crores in Q2 FY27 indicates growth in core business activities.
💰
Financial Impact
Net profit for Q2 FY27 increased to Rs. 387.29 Crores, and for H1 FY27 to Rs. 760.58 Crores, showing improved profitability compared to prior periods.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders benefit from the reported growth in revenue and net profit, which contributes to the company's overall financial health and equity increase to Rs. 8,576.48 Crores.
🔍
Management Signal
The financial results indicate management's focus on operational efficiency and revenue generation, resulting in increased profitability for the quarter and half-year.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — examine sustained revenue and profit growth.
Progress on Krebs Biochemicals & Industries Ltd. amalgamation approval.
Updates on new Labour Codes impact and any further exceptional items.
LOW RISK No significant new risks or concerns identified in the financial results filing.
💡 Investor Takeaway
Ipca Laboratories' standalone Q2 FY27 revenue from operations reached Rs. 2,255.61 Crores, a 16.85% increase from Q2 FY26. Net profit rose 27.08% to Rs. 387.29 Crores for Q2 FY27, reflecting improved financial performance across key metrics.
⚖️ Strengths & Concerns

✅ Positives

  • Standalone revenue from operations for Q2 FY27 grew by 16.85% to Rs. 2,255.61 Crores from Rs. 1,930.32 Crores in Q2 FY26.
  • Net profit for the period in Q2 FY27 increased by 27.08% to Rs. 387.29 Crores from Rs. 304.74 Crores in Q2 FY26.
❓ Frequently Asked Questions
What was Ipca Laboratories' standalone revenue from operations for Q2 FY27?
Ipca Laboratories reported standalone revenue from operations of Rs. 2,255.61 Crores for the quarter ended September 30, 2026 (Q2 FY27).
What was Ipca Laboratories' standalone net profit for Q2 FY27?
The standalone net profit for Ipca Laboratories for Q2 FY27 was Rs. 387.29 Crores, compared to Rs. 304.74 Crores in Q2 FY26.
What were Ipca Laboratories' standalone earnings per share (EPS) for Q2 FY27?
Ipca Laboratories' basic/diluted earnings per share (after exceptional items) for Q2 FY27 was Rs. 15.27 per share.
What was Ipca Laboratories' half-year standalone revenue from operations for H1 FY27?
For the half year ended September 30, 2026 (H1 FY27), Ipca Laboratories' standalone revenue from operations was Rs. 4,374.85 Crores.
What was Ipca Laboratories' total equity as of September 30, 2026?
As of September 30, 2026, Ipca Laboratories' total equity stood at Rs. 8,576.48 Crores.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.